Skip to content

Project Lung Cancer Screening in Southern Denmark

Project Lung Cancer Screening in Southern Denmark

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06537804
Acronym
PLUS
Enrollment
1332
Registered
2024-08-05
Start date
2024-08-05
Completion date
2026-12-31
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

One thousand randomly selected voluntary citizens aged 60-74 years old, who are heavy current or former smokers with an increased risk of developing lung cancer may be included in the project. The participants will be identified through an initial questionnaire survey concerning smoking history and general health. Project participants are offered a low-dose CT (LDCT) scan annually for three consecutive years. In relation to the first scan, a lung function test will also be performed. The screening process will be evaluated for possible national implementation of a lung cancer screening program in Denmark.

Detailed description

This pilot study is a prospective interventional feasibility study. The primary goal is to evaluate the impact on healthcare organization, administration of resources and costs, and thereby assessing the feasibility of implementing systematic screening for lung cancer among people at high risk in Denmark (current or former heavy smokers). The pilot study will be performed on Funen in the Region of Southern Denmark and will run over three years (2024-2026). One thousand randomly selected participants aged 60-74 years old, who meet the screening criteria, will receive annual LDCT scans for three consecutive years. Data will be collected continuously throughout the study period. The analysis method will focus on descriptive statistics to display questionnaire response and participation rates, and assess the impact of screening on healthcare organization and resources. Furthermore, the result including direct and indirect effects of the screening process (e.g. number of positive findings, false positive results, and follow-up rates). The analyses will also include healthcare economics including resource consumption as well as qualitative assessments to describe potential differences between the screening population versus a corresponding control group of heavy smokers. Finally, the radiologists' assessments of the project's LDCT scans are compared to the assessment of an artificially intelligent algorithm to explore the opportunities of supporting a future national screening program.

Interventions

RADIATIONScreening by low-dose CT scan

Screening for lung cancer by low-dose CT scan

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Heavy smokers (≥ 30 pack years) or citizens with a PLCOm2012 calculated 6-year risk of lung cancer \> 2%. * Age: 60-74 years old * Residence on Funen and surrounding islands

Exclusion criteria

* Cancer treatment or follow-up (except non melanoma skin cancer and similar low malignant cancers) within the past 12 months * CT scan performed within the past 12 months

Design outcomes

Primary

MeasureTime frameDescription
Lung cancer screening cost-effectiveness analysis quantified in the form of incremental cost-effectiveness ratio thresholdUp to 36 monthsratio

Secondary

MeasureTime frameDescription
Characteristics of citizens from the cohort based on registry dataUp to 36 monthsRegistry data
Participation rate36 months (complete study period)Number and percentage of citizens completing the screening trial
Dropouts36 months (complete study period)Number and percentage of citizens included that dropout during the study period
Lung cancer found on low dose CT-scansBaseline, after 1 year, after 2 yearsNumber and percentage
FEV1BaselineMeasured in liters by a lung function test
FVCBaselineMeasured in liters by a lung function test
Treatment diagnose - cancer36 months (complete study period)number and percentage of treatments by action diagnosis related to cancer
Hospitalization time36 months (complete study period)Hospitalization time related to lung cancer diagnosis measures in days
Treatment diagnose - any other disease (found on low dose CT scans)36 months (complete study period)number and percentage of treatment diagnosis related to findings of other diseases (by action diagnosis)
Inconclusive or non-malignant findings on low dose CT scansBaseline, after 1 year, after 2 yearsNumber and percentage
Self reported health and quality of life assessed by the EQ-5D-5L questionnairBaseline and after 2 yearslevel of percieved problems are coded from level 1 to 5 in 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression
Self-reported smoking statusBaseline, after 1 year, after 2 yearsYes/no/former smoker
All-cause-mortality36 months (the entire study period)Number of deaths in both groups (intervention/no intervention)
GenderBaselineMale/female
WeightBaselineKilogram
HeightBaselineCentimeters
Smoking historybaselineaccording to the PLCOm2012 risk model
Total time consumption of extra work at involved departments: department of lung diseases, department of radiology and department og pulmonary diseases36 monthshours
Referral to follow-up procedures36 months Entire study periodNumber of referrals

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026